IU Scientists Develop New Bone Marrow Imaging Technique
         | Newswise

IU Scientists Develop New Bone Marrow Imaging Technique | Newswise

Newswise — INDIANAPOLIS — Indiana University School of Medicine scientists have developed a powerful new imaging technique to study bone marrow in mouse models. By overcoming key challenges unique to imaging this complex tissue, this advancement could support future drug development and therapies for conditions involving bone marrow, including cancers, autoimmune diseases and musculoskeletal disorders….

Read More
The Wistar Institute, The University of Leeds, and the Perelman School of Medicine Discover New ‘Molecular Glues’ as a Possible Therapeutic Approach for Autoimmune Conditions | Newswise

The Wistar Institute, The University of Leeds, and the Perelman School of Medicine Discover New ‘Molecular Glues’ as a Possible Therapeutic Approach for Autoimmune Conditions | Newswise

Newswise — PHILADELPHIA — (April 14, 2025) —The Wistar Institute’s Joseph Salvino, Ph.D., — in collaboration with Elton Zeqiraj, Ph.D., of The University of Leeds and Roger Greenberg, M.D., Ph.D., of The Perelman School of Medicine at the University of Pennsylvania — has discovered a type of “molecular glue” that can be used to inhibit…

Read More
ADVISORY: Media Briefing on the Disease-fighting Promise of mRNA | Newswise

ADVISORY: Media Briefing on the Disease-fighting Promise of mRNA | Newswise

Newswise — Researchers are studying messenger RNA’s potential to treat and prevent an array of serious conditions—including cancer. In a briefing for journalists by Johns Hopkins University and Medicine, mRNA researchers will offer broad perspective on the history and development of this technology and discuss its future promise as the foundation for treatments for conditions…

Read More
5 Things Parents Need to Know About Multiple Sclerosis | Newswise

5 Things Parents Need to Know About Multiple Sclerosis | Newswise

Newswise — Parents of children who have been diagnosed with multiple sclerosis likely have many questions about their child’s condition. Receiving a diagnosis can be overwhelming and searching for information online can turn up complicated explanations. Laura Saucier, MD, MSc, a neuroimmunologist in the Neurological Institute at Children’s Hospital Los Angeles, breaks down the key…

Read More
5 Things Parents Need to Know About Multiple Sclerosis | Newswise

Precision Medicine Uses AI to Predict Protein Kinase Treatment Targets | Newswise

Newswise — Protein kinase research presents an opportunity to explore molecular targets in the body to treat diseases like cancer and autoimmune disorders. These enzymes have the potential to bind to cellular sites and inhibit dysfunctional behavior, such as the overproduction of cancerous cells and tumor formation. With the vast combination of possible kinase and…

Read More
5 Things Parents Need to Know About Multiple Sclerosis | Newswise

New Research Sheds Light on Why Scleroderma Affects Mostly Women and How to Treat It | Newswise

Newswise — Two new studies led by researchers at Hospital for Special Surgery (HSS) have uncovered key biological mechanisms driving systemic sclerosis (SSc), or scleroderma – a rare and often devastating autoimmune disease that causes fibrosis (tissue hardening) and inflammation. The research, published in the March issue of the Journal of Experimental Medicine, helps explain…

Read More
5 Things Parents Need to Know About Multiple Sclerosis | Newswise

Pacientes com doença de pele respondem a tratamento direcionado | Newswise

Newswise — PHOENIX — Pesquisadores da Mayo Clinic identificaram uma terapia direcionada que pode trazer alívio para as pessoas que vivem com líquen plano, uma condição inflamatória crônica da pele, cabelo, unhas, boca e genitais. Eles descreveram suas descobertas em um estudo publicado no Journal of Clinical Investigation, relatando seu primeiro ensaio clínico em humanos, fase 2….

Read More
5 Things Parents Need to Know About Multiple Sclerosis | Newswise

Houston Methodist Researchers Identify Key Protein to Potentially Halt Autoimmune Diseases and Allergies | Newswise

Newswise — HOUSTON-(Jan. 21, 2025) – Houston Methodist researchers have identified a key protein as a potential therapeutic target for stopping the body’s immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and allergies.  The paper titled “Apex1 safeguards genomic stability to ensure a cytopathic T cell fate in autoimmune disease…

Read More